E-cigarettes with a mint flavor are more likely to deteriorate lung health.

Published Date: 24 Apr 2023

Adding mint flavor to e-cigarette liquids increases the amount of vapour particles produced and is linked, according to a recent study published in Respiratory Research.

Read Full News

Latest News

PAP Therapy May Reduce Pulmonary Pressures in Sleep Apnea

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon to Stock Lilly's New Weight-loss Pill At US Kiosks, Offer Same-day Delivery

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Treprostinil Can Slow Lung Decline in Pulmonary Fibrosis

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

Can Past Sleep Problems Hinder Smoking Cessation?

People with existing sleep problems may find it harder to quit smoking when seeking help to stop using tobacco.

Fan-to-Face Therapy May Ease Breathlessness in Lung Disease

Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training sessions and improves training tolerability in patients with chronic lung disease.

Preterm BPD May Reduce Exercise Capacity at School Age

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Todays Updates

Early Tislelizumab May Boost PFS in Esophageal Cancer

For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.

ctDNA Predicts Relapse in Locally Advanced Cervical Cancer

Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.

GLP-1 RAs May Lower Hysterectomy Risk in Endometrial Cancer

There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.

Latest News

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Amazon.com said on Thursday its pharmacy unit will stock Eli Lilly's new weight-loss pill at kiosks located at some of the company's ⁠primary care clinics and offer same-day...

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with idiopathic pulmonary fibrosis.

People with existing sleep problems may find it harder to quit smoking when seeking help to stop using tobacco.

Adding fan-to-face therapy to a supervised exercise training program lowers exertional breathlessness across training sessions and improves training tolerability in patients with chronic lung disease.

School-aged children born prematurely with bronchopulmonary dysplasia may have exercise-related limitations compared with healthy term-born peers.

News All Time

New CHEST Recommendations Guide Biologic Use for Severe Asthma

New CHEST Recommendations Guide Biologic Use for Severe Asthma

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

FDA Clears LEADOPTIK's LIA System for Higher-Accuracy Lung Biopsy

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

Stopping Inhaled Corticosteroids or LAMA in COPD Linked to Early Exacerbations

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

From GOLD to Ground Level: Navigating Biologic Use in COPD Care

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Bronchodilator Response Outperforms Genetic Risk in Predicting COPD Progression

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

Additional Phase 2 REVERT IPF Data Shows Greater Fibrosis Reduction With TTI-101

5 Pulmonology Headlines You Missed in December 2025

5 Pulmonology Headlines You Missed in December 2025

Q4 2025 Recap: Pulmonology News and Updates

Q4 2025 Recap: Pulmonology News and Updates

Pulmonology in 2025: Year in Review

Pulmonology in 2025: Year in Review

Asthma in 2025: Year in Review

Asthma in 2025: Year in Review

COPD in 2025: Year in Review

COPD in 2025: Year in Review

Characterizing COPD - Lung Cancer Patients, with Joseph Friedberg, MD Joseph Friedberg, MD, Kevin Kunzmann

Friedberg discusses the inconsistent clinical pathways from disease progression to intervention in patients with a pair of highly deadly lung diseases.

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Post-NICU PM2.5 Exposure Raises Asthma Risk in Children With Bronchopulmonary Dysplasia

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

Asthma Biologic Adherence Shaped by Psychological, Clinical, Systemic Factors

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Nerandomilast (Jascayd) Tablets for Progressive Pulmonary Fibrosis

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

FDA Approves Depemokimab-ulaa (Exdensur) for Severe Asthma

Recommended News For You

Gene therapy for glioblastoma is effectively created by researchers.

Reduced Suicide Rates in Cancer Patients; Enhanced Circadian Rhythm; HIV Vaccine for Cancer Patients?

New Gene Therapy Nears EU Nod for Bladder Cancer

Risk-Benefit Analysis of CAR-T Therapies for Myeloma is Muddy by Early Death Risk.

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know

Recommended Articles For You

Understanding Melanoma: From Diagnosis to Healing and Excision in Denver 

Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management 

Unlocking the Power of Cryoprecipitate: A Comprehensive Guide 

Case Study: Personalized Medicine Based on Genetic Profiling in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Making informed decisions and managing regret after prostate cancer treatment

2.

Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic

3.

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says

4.

Hypnotherapy may offer real benefits for cancer patient care

5.

Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients

1.

How to Prevent Tumor Lysis Syndrome in Cancer Patients

2.

Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection

3.

Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights

4.

Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control

5.

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

2.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

Navigating the Complexities of Ph Negative ALL - Part XII

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot